Week 340 Review - Most of last week's gains are gone

It looks like last week was a blip, as we're back to normal this week with nearly all last week's gains wiped out. It was a slightly positive week until Friday, when a 1p drop in OPTI:Optibiotix led to a nosedive. The deficit between cost and value widened by £1,451 to £57,302 and portfolio value dropped back bellow £100k to £99,157.

There were no big fallers this week, which usually signals a positive week.

FXPO:Ferrexpo climbed 6% as tensions in the Ukraine began to ease slightly, but these are still 38% down so have a lot of recovering to do before my annual review date on 28th May.

BLU:Blue Star Capital have been very volatile lately, but in a good way this week as they went up by 8%. They are still 44% down but if there is any half decent news about Satoshipay then they could recover very quickly.

Share of the Week by miles is JLP:Jubilee Metals which increased by a spectacular 60% of my original purchase price and is now 300% up. I'm expecting this momentum to continue as they are well below fair price for the income they are now generating.

At least the drop wasn't enough to take us below the injection line.

I'm really struggling to get above the trend line.

Here's the ISA and shares portfolio after week 28 of year 7.

			Weekly Change
Cash	£29.55		-£3.75
Portfolio cost	£72,195.21		+£0
Portfolio sell value (bid price-commission)	£46,087.77	(-36.2%)	-£479.21
Potential profits	£2,615.29		+£520
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£567.04	(15.4%)	-£21.60
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£367.69	(10.0%)	-£1.13
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

Not too big a drop here thanks to the increase in value of JLP:Jubilee Metals by £520. It's taking all my willpower not to cash in any more profits here, but I've already sold too many so really need to hold these long term. There's no reason why they can't get to 100p in the next 5 years given the speed of growth, at which point I'll only need to sell 1,000 for each £1,000 to spend on something else instead of needing to sell 6,000 now.

Annual performance is still great and long term performance has just about stayed on 10% for another week.

Such a long way to get back to the cost line.

Well below the trend line and dragging it steeper

The SIPP looks like this after week 324 overall and week 12 of year 7.

			Weekly Change
Cash	£67.14		-£504.33
Portfolio cost	£81,534.58		+£1,007.64
Portfolio sell value (bid price - commission)	£51,925.42	(-36.3%)	-£994.85
Potential profits	£118.19		-£6.06
Yr 7 Dividends	£81.54		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£0
Yr 7 projected avg monthly profit	£148.86	(3.6%)	-£20.11
Total Dividends	£3,285.93		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£0
Average monthly cash profit	£354.68	(8.5%)	-£1.32
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	53%		-1%

A lot happened this week.

Firstly me regular monthly purchase of iShares Physical Gold went through. I got 4 units at 2634.315p costing £106.87 after commission. That takes my holding up to 20 units and they are still flat, down by just £1.

Next I did what I usually do when OPTI:Optibiotix drops in price. I cheered myself up by buying some more. I had some cash in my AJ Bell account so I added £280 from my bank account as it's payday next week, and bought another 1,000 shares at 43.98p costing £449.75. That takes my total OPTI holding to 175,069. I should really stop now, but after six and a half years I'm still convinced in the story. The first generation products have got us to break even despite not being on the market for long, but the second generation products have staggering potential. I still see this as my retirement share.

I also had cash in my Hargreaves Lansdown SIPP and I've been beyond frustrated with the share price action of DDDD:4D Pharma, so I added £240 from my bank account and bought 1,254 shares at 35.0127p costing £451.01. I now have 15,139 of these but this purchase only dragged my SIPP average down from 130p to 107p, and my ISA average is 115p so they are down by 70%. I would buy loads more at this level, but I've been stung badly by pharma companies before so I daren't risk it, as the £17,000 I've spent on these already would wipe out half of my profits if they go bust.

This account fared much worse than the ISA as there was no star performer to mend the hole left by the OPTI:Optibiotix drop. Annual performance is woeful as I can't sell anything, and long term average slipped another 0.1%, with compound performance also dropping thanks to the increase in injection.

This is so deceptive as it looks almost flat for the last 12 months, but the cost line has been steadily rising as I bank profits and inject more cash.

There's the real picture. Woe and desperate misery.

The trading account looks like this after week 290 overall and week 30 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£788.04	(-66.8%)	+£22.86
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£14.91	(7.5%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

Remarkably this account has gone up two weeks in a row. Only by £22, but I'm not complaining. This week it was thanks to HUM:Hummingbird Resources and IQE:IQE, but in spite of DDDD:4D Pharma which dropped yet again.

Given the complete catastrophe this account has been, the long term performance of 7.5% is fairly remarkable, assuming I ever break even on my current holdings.

If this is the start of a recovery then it's going to take a long time at the current rate.

I need to get above the trend line next week to boost my morale.

It's pay day on Tuesday which means at the end of the week I will have enough money in my work pension to transfer some into my SIPP. I reckon I'll have about £2,400. I'm determined to stick to my plan and buy magic formula shares. One that qualifies for magic formula is CAML:Central Asia Metals, and I hate not being invested so will almost certainly get back in there. I sold them for 237p and the current price is 234p so they are virtually unchanged since then. The dividend ex-date is in April, so buying now will get me that too.

I've not completely refreshed my magic formula rankings as it would take forever, so I've re-ranked on P/E ratio because that's automatic, and updated the stats for a few of the top-ranked shares so see how they compare. I risk missing an amazing company that's emerged via recent results, but I can live with that until my next injection in June. The leader is ASHM:Ashmore Group, so assuming there are no changes between now and the transfer, those will be my other buy. Their stats have all improved since I last ran my calculations, and it appears they are taking advantage of a troubled market to invest in a few bargains in emerging markets. Their dividend ex-date is early March so I may just have time. If it looks like there will be a delay I may sell PAF:Pan African Resources as they have no dividend until December, buy ASHM:Ashmore Group now, and then buy back PAF when the cash comes through, as my review date for them isn't until November so I'll definitely want to have some for the next dividend.